<DOC>
	<DOCNO>NCT02589587</DOCNO>
	<brief_summary>Morbidly obese patient exhibit impaired secretion satiation hormone may contribute development obesity . Bariatric surgery associate weight loss dramatic increase secretion satiation hormone , underlie mechanism remain unknown . The investigator 's goal therefore examine patient sleeve gastrectomy compare finding lean control .</brief_summary>
	<brief_title>Enteroendocrine Cells Before After Sleeve Gastrectomy</brief_title>
	<detailed_description>Morbidly obese patient exhibit impaired secretion satiation hormone cholecystokinin ( CCK ) , glucagon-like peptide 1 ( GLP-1 ) peptide YY ( PYY ) , may contribute development obesity . Bariatric surgery associate weight loss dramatic increase secretion satiation hormone , underlie mechanism remain unknown . A good understanding mechanism involve assist development non-invasive therapeutic strategy . The investigator 's goal therefore examine patient sleeve gastrectomy compare finding lean control . Gastric intestinal mucosa collect endoscopy morbidly obese subject 3 month sleeve gastrectomy . In Addition , lean control examine . Expression various gut peptide assess immunohistochemistry quantitative polymerase chain reaction ( PCR ) .</detailed_description>
	<criteria>Morbidly obese patient schedule sleeve gastrectomy BMI &gt; 35 kg/m2 Age : &gt; 1865 year Lean , healthy control BMI &gt; 18 &lt; 28kg/m2 Age : &gt; 1840 year Bleeding diathesis Previous surgery gastrointestinal tract ( appendectomy acceptable )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>